Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences (EXAS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results ...

University research in Wisconsin led to $500 million Third Wave business, screening tests for cancer, including Cologuard ...

With rates of colorectal cancer (CRC) surging among younger populations, Guardant Health is turning to a famous face beloved ...

Although summer is in full swing, Valve is already looking to the future. The company has released a detailed schedule of ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...

Matt Ryan is once again heating up the topic of the Assassin's Creed IV: Black Flag remake. Although he avoided clear answers ...

Check out our EXAS stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Find out if Exact Sciences Corp (EXAS:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the company's ...